Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-cr
Novartis India's board on Tuesday approved the sale of its OTC division to GlaxoSmithKline Consumer Pvt Ltd, a consumer healthcare joint venture between Novartis AG and GSK, for a consideration of Rs 109.7 crore.
Jan 13, 2015, 19:15 PM IST